Fighting cancer with next generation iTANK-armed CAR T-cells and oncolytic viruses

News & Press Releases

All news
Harnessing the patient’s immune system to fight cancer
Read more
A universal CAR T-cell enhancement technology platform
Read more
The company’s product portfolio consists of four drug candidates
Read more

Get to know Elicera Therapeutics

Elicera's strengths are based on a deep understanding of how cells and viruses can be genetically engineered to trigger a powerful immune response to cancer.

Di Yu, Head of Technical Operations and co-founder, tells more about Elicera in the film.

About Elicera

iTANK-technology platform

A universal CAR T-cell technology platform, compatible with any CAR T-cell therapy for a multi-targeted attack on solid tumors.

Upcoming events and presentations

September 4, 2024
ISCT Europe 2024 Regional Meeting
Read more (external link)
September 8, 2024
CICON24 (Eighth International Cancer Immunotherapy Conference)
Read more (external link)
September 12, 2024
Biostock Investor Meeting
Read more (external link)
September 18, 2024
NLSDays 2024
Read more (external link)
November 19, 2024
Biostock Summit
Read more (external link)
All Events and Presentations
Watch our latest company presentation

Sign up for Press Releases

By filling out the form you are approving that Elicera stores your information. Read more about our integrity policy here.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.